台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    80.0
  • 漲跌
    ▲0.4
  • 漲幅
    +0.50%
  • 成交量
    478
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-元富-信義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2603/1003/2004/0104/1404/2404/2660708090100110May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-信義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/1600.00179.0078.90-12,135-0.05%
2025/04/0900.001169.2066.80-112,377-0.46%
2025/04/08471.6500.0071.3042,3310.17%
2025/04/02388.5300.0087.9032,2940.13%
2025/03/28593.9600.0093.8052,2570.22%
2025/03/27296.20296.9096.1002,2480.00%
2025/03/26197.50298.9598.10-12,230-0.04%
2025/03/25198.50198.5098.6002,2100.00%
2025/03/2400.0011898.9399.00-1182,192-5.38% 大賣/鉅額交易
2025/03/21596.006597.9396.40-602,149-2.79%
2025/03/20895.281895.5195.80-102,123-0.47%
2025/03/1900.00293.2092.80-22,098-0.10%
2025/03/17292.0000.0091.9022,0770.10%
2025/03/14292.50292.0592.5002,0870.00%
2025/03/13591.10598.4091.6002,0990.00%
2025/03/10297.80297.1597.8002,0160.00%
2025/03/07297.80199.2096.5011,9910.05%
2025/03/06194.30196.0094.3001,9570.00%
2025/03/03194.1000.0094.2011,8870.05%
2025/02/26199.0000.0098.0011,8860.05%
2025/02/243399.2733101.4899.3001,7960.00%
2025/02/2123102.3231101.5198.90-81,727-0.46%
2025/02/2000.00198.8099.70-11,553-0.06%
2025/02/19195.501.195.1995.20-0.11,5100.00%
2025/02/18493.78496.6594.0001,4910.00%
2025/02/176299.1068101.6897.10-61,440-0.42%
2025/02/1400.00397.8398.90-31,226-0.24%
2025/02/13193.9000.0094.0011,1520.09%
2025/02/1200.00193.2093.00-11,152-0.09%
2025/01/1500.00187.1086.20-11,157-0.09%
2025/01/140.489.101.488.3087.30-11,147-0.09%
2025/01/13691.70791.8189.90-11,132-0.09%
2025/01/10790.171588.9190.50-81,064-0.75%
2025/01/092188.441594.1687.5061,0140.59%
2025/01/0829100.2810.2100.8497.2018.88722.16%
2025/01/075.291.512389.9392.70-17.8649-2.74%
2025/01/0600.00291.3089.80-2611-0.33%
2025/01/03287.70188.7088.3016000.17%
2025/01/0200.00487.8587.00-4591-0.68%
2024/12/3100.00186.0086.00-1590-0.17%
2024/12/30186.0000.0085.5015930.17%
2024/12/27285.80286.1085.8005930.00%
2024/12/2600.00685.3086.30-6592-1.01%
2024/12/25183.3000.0083.9015890.17%
2024/12/24283.4500.0082.9025970.33%
2024/12/23383.00383.6382.9006120.00%
2024/12/2000.00182.3082.10-1613-0.16%
2024/12/1700.00181.7082.00-1625-0.16%
2024/12/1600.00782.1981.80-7631-1.11%
2024/12/13783.092482.7183.00-17627-2.71%
2024/12/12585.8800.0085.1056240.80%
2024/12/11386.77288.0086.0016210.16%
2024/12/10289.6000.0087.5026150.33%
2024/12/092488.4300.0090.10246004.00%
2024/12/0600.00189.0087.60-1573-0.17%
2024/11/2500.00185.0085.00-1543-0.18%
2024/11/12082.4000.0082.5005350.00%
2024/11/0100.00982.3082.80-9606-1.48%
2024/10/3000.00182.6081.40-1601-0.17%
2024/10/28883.65881.0081.0005840.00%
2024/10/2500.00181.6081.40-1567-0.18%
2024/10/2300.00282.0081.80-2570-0.35%
2024/10/22179.10178.1080.6005620.00%
2024/10/14174.00174.3074.0006140.00%
2024/10/1100.00174.7074.70-1619-0.16%
2024/10/09275.6500.0073.9026220.32%
2024/09/182081.40281.0081.40186652.71%
2024/09/040.281.5000.0081.300.27420.03%
2024/09/02486.6300.0085.3047530.53%
2024/08/3000.00386.3786.40-3750-0.40%
2024/08/2800.00183.8083.70-1733-0.14%
2024/08/260.480.4000.0080.400.47340.06%
2024/08/2200.00281.6081.30-2759-0.26%
2024/08/0900.00378.6078.40-3785-0.38%
2024/08/0800.00376.7776.70-3783-0.38%
2024/08/06266.8000.0070.3027710.26%
2024/08/05574.50274.3074.0037340.41%
2024/07/3100.00283.3082.60-2732-0.27%
2024/07/19190.3000.0086.5017270.14%
2024/07/1700.000.388.0088.10-0.3713-0.04%
2024/07/090.184.3000.0084.100.18100.01%
2024/07/08086.7000.0086.0008290.00%
2024/07/0500.000.387.5086.80-0.3856-0.04%
2024/07/04087.010.387.0086.90-0.3889-0.03%
2024/07/03087.9000.0087.4009530.00%
2024/06/25086.6000.0087.8001,1210.00%
2024/06/24087.401587.3586.70-151,128-1.33%
2024/06/21188.6000.0088.9011,1210.09%
2024/06/1700.000.491.3091.50-0.41,153-0.03%
2024/06/14190.8000.0090.9011,1580.09%
2024/06/11192.9000.0091.0011,1820.08%
2024/05/3100.00189.0090.10-11,420-0.07%
2024/05/2900.00190.4089.10-11,511-0.07%
2024/05/2800.00189.0088.70-11,555-0.06%
2024/05/2400.000.187.0087.20-0.11,8690.00%
2024/05/2300.00287.9087.10-22,014-0.10%
2024/05/170.187.7500.0087.700.12,1700.00%
2024/05/15186.8000.0086.4012,2110.05%
2024/05/06288.0000.0088.0022,3310.09%
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-17天前
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕 相關文章